Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk.

MLA

Lahu, Shqipdona, et al. “Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk.” Circulation: Cardiovascular Interventions, vol. 15, no. 10, Oct. 2022, p. e012204. EBSCOhost, https://doi.org/10.1161/CIRCINTERVENTIONS.122.012204.

APA

Lahu, S., Presch, A., Ndrepepa, G., Menichelli, M., Valina, C., Hemetsberger, R., Witzenbichler, B., Bernlochner, I., Joner, M., Xhepa, E., Hapfelmeier, A., Kufner, S., Rifatov, N., Sager, H. B., Mayer, K., Kessler, T., Laugwitz, K.-L., Richardt, G., Schunkert, H., & Neumann, F.-J. (2022). Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk. Circulation: Cardiovascular Interventions, 15(10), e012204. https://doi.org/10.1161/CIRCINTERVENTIONS.122.012204

Chicago

Lahu, Shqipdona, Antonia Presch, Gjin Ndrepepa, Maurizio Menichelli, Christian Valina, Rayyan Hemetsberger, Bernhard Witzenbichler, et al. 2022. “Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk.” Circulation: Cardiovascular Interventions 15 (10): e012204. doi:10.1161/CIRCINTERVENTIONS.122.012204.